These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10949702)

  • 21. Pharmacogenetics of antihypertensive treatment.
    Arnett DK; Claas SA; Glasser SP
    Vascul Pharmacol; 2006 Feb; 44(2):107-18. PubMed ID: 16356784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of antihypertensive drugs on glucose metabolism and cardiovascular events].
    Landmark K; Reikvam A
    Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1740-4. PubMed ID: 19756054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Why heart failure clinics?].
    Hülsmann M; Pacher R
    Wien Klin Wochenschr; 2002 Oct; 114(19-20):819-21. PubMed ID: 12503472
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of cardiac insufficiency].
    Hertault J
    Soins Cardiol; 1983 Oct; (8):13-20. PubMed ID: 6558860
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hypertensive patients have to be doubly treated earlier. Which antihypertensive drug combination is appropriate to whom?].
    MMW Fortschr Med; 2003 May; 145(22):56. PubMed ID: 12866285
    [No Abstract]   [Full Text] [Related]  

  • 26. [Fewer cases of stroke, atrial fibrillation, diabetes and renal insufficiency. Good treatment of hypertension is more than lowering of blood pressure].
    Baumgart P
    MMW Fortschr Med; 2008 Jan; 150(1-2):52-3. PubMed ID: 18300647
    [No Abstract]   [Full Text] [Related]  

  • 27. Persistent formation of angiotensin II despite treatment with maximally recommended doses of angiotensin converting enzyme inhibitors in patients with chronic heart failure.
    Hanon S; Vijayaraman P; Sonnenblick EH; Le Jemtel TH
    J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2):147-50. PubMed ID: 11967806
    [No Abstract]   [Full Text] [Related]  

  • 28. Optimal pharmacologic and non-pharmacologic management of cardiac transplant candidates: approaches to be considered prior to transplant evaluation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006.
    Jessup M; Banner N; Brozena S; Campana C; Costard-Jäckle A; Dengler T; Hunt S; Metra M; Rahmel A; Renlund D; Ross H; Warner Stevenson L
    J Heart Lung Transplant; 2006 Sep; 25(9):1003-23. PubMed ID: 16962463
    [No Abstract]   [Full Text] [Related]  

  • 29. [ACE inhibitors, beta blockers, AT-1 antagonists in heart failure. Right dosage and combination].
    Fliri M
    MMW Fortschr Med; 2002 Nov; 144(48):38-43. PubMed ID: 12532542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Beta-blockers and cardiac insufficiency: a cultural revolution?].
    Komajda M
    Arch Mal Coeur Vaiss; 1998 Dec; 91(12):1449-51. PubMed ID: 9891826
    [No Abstract]   [Full Text] [Related]  

  • 31. A survey of outpatient management of elderly heart failure patients in Poland-treatment patterns.
    Rywik TM; Rywik SL; Korewicki J; Broda G; Sarnecka A; Drewla J
    Int J Cardiol; 2004 Jun; 95(2-3):177-84. PubMed ID: 15193817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.
    Azadpour M; Lamas GA
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):891-902. PubMed ID: 15500434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular basis for therapeutic choices in heart failure.
    Opie LH
    Circulation; 2004 Oct; 110(17):2559-61. PubMed ID: 15505109
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment practices in heart failure with preserved left ventricular ejection fraction: a prospective observational study.
    Peltier M; Houpe D; Cohen-Solal A; Béguin M; Levy F; Tribouilloy C
    Int J Cardiol; 2007 Jun; 118(3):363-9. PubMed ID: 17049391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-related underutilization of angiotensin-converting enzyme inhibitors in older hospitalized heart failure patients.
    Ahmed A; Allman RM; DeLong JF; Bodner EV; Howard G
    South Med J; 2002 Jul; 95(7):703-10. PubMed ID: 12144075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Is heart rate reduction beneficial to patients with heart insufficiency? Focus on beta-blockade].
    Henriksen OM; Gadsbøll N
    Ugeskr Laeger; 2002 Jan; 164(5):615-9. PubMed ID: 11871210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elderly patients undergoing major vascular surgery: risk factors and medication associated with risk reduction.
    Feringa HH; Bax JJ; Karagiannis SE; Noordzij P; van Domburg R; Klein J; Poldermans D
    Arch Gerontol Geriatr; 2009; 48(1):116-20. PubMed ID: 18177954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular drug therapy in the elderly.
    Aronow WS; Frishman WH; Cheng-Lai A
    Cardiol Rev; 2007; 15(4):195-215. PubMed ID: 17575484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are you missing your "must-use" medications?
    Harv Heart Lett; 2003 Apr; 13(8):6-7. PubMed ID: 12711577
    [No Abstract]   [Full Text] [Related]  

  • 40. [Role of angiotensin-converting enzyme inhibitors in the treatment of heart failure in the 21st century].
    Gibelin P
    Arch Mal Coeur Vaiss; 2002 Feb; 95 Spec 4(5 Spec 4):41-5. PubMed ID: 11933555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.